“PROSPECTS OF COMBINING INTERLEUKIN-2 WITH IMMUNE CHECKPOINT INHIBITORS FOR CANCER THERAPY” (2020) Voprosy onkologii, 66(1), pp. 23–28. doi:10.37469/0507-3758-2020-66-1-23-28.